• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RNE
Click for more information
0.00% 0.2¢

RENU ENERGY LIMITED - Corporate Spotlight

Market Cap $1.206M  ! watchlist Created with Sketch. Add to my watchlist
Utilities Utilities - Independent Power Producers

ReNu Energy Limited is an Australia-based company, which delivers clean energy products... ReNu Energy Limited is an Australia-based company, which delivers clean energy products and services. The Company focuses on investing in renewable and clean energy technologies and driving zero-emission green hydrogen projects for a more sustainable future. Its segments include hydrogen and renewable and clean energy investments. Its projects include Countrywide Hydrogen, Tasmanian Green Hydrogen Project, Vaulta, Allegro Energy, Enosi Australia, and Uniflow Power. Countrywide Hydrogen is developing five renewable hydrogen projects, three in Tasmania and two in Victoria, with additional projects in its pipeline, both locally and offshore, to supply the growing demand for green hydrogen. Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Enosi Australia uses smart metering data to trace, match and settle energy production and consumption to reduce its impact on climate change. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
0.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $1.206M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
117 130622450 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 7007851 13
View Market Depth
Last trade - 11.01am 02/10/2024 (20 minute delay) ?
RNE (ASX) Chart

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.